Navigation Links
Shawn Hanley Named KePRO Director of Business Development - Public Programs
Date:2/10/2009

Mr. Hanley will spearhead public sector business growth

Harrisburg, PA (PRWEB) February 10, 2009 -- KePRO, a leading quality improvement and care management organization, named Shawn Hanley as Business Development Director, Public Programs. He will be responsible for expanding KePRO's public sector market share and the company's overall revenue.

"Shawn brings over 10 years of experience helping organizations assist government agencies meet quality, cost, and health care objectives," said KePRO's chief development officer, Andrew Weintraub. "KePRO has a substantial presence in the public program market, and Shawn's extensive experience with the federal and numerous state government agencies will enrich our pipeline and support the goals of our public sector clients."

Mr. Hanley will work with federal, state, and local government agencies to improve health outcomes while reducing the financial and administrative burden of providing health care.

"I am excited about the quality, financial, and clinical focus of KePRO, and look forward to leverage my existing relationships with members of the legislative and executive branches across the country to expand KePRO's public sector market share," said Hanley. "KePRO's integrated care management services will help governments reduce costs while improving health outcomes through evidence-based, member-centric programs."

Mr. Hanley has over 20 years of experience, most recently as the Principle of Shawn Hanley and Associates, where he helped clients gain key access to, and an understanding of, government procurement opportunities. He graduated with a B.S. in Political Science from the University of Illinois at Chicago, is a graduate of the Coverdell Leadership Institute, and was honorably discharged from the United States Marine Corps. He served in the Department of Veteran Affairs for three years, where he was awarded the Meritorious Service Award from the Secretary. Hanley is also past member of both the Board of Advisors and the Board of Directors for the Atlanta Chambers of Commerce.

About KePRO
KePRO, a leading quality improvement and care management organization, offers innovative and outcomes-focused solutions to reduce the utilization of health care resources and optimize quality of care for public and commercial clients. KePRO's comprehensive, member centric care management solutions go far beyond traditional utilization and case management by coordinating the care provided to members with acute, chronic and complex conditions across the continuum, and identifying members who are at the highest risk for future services, but have not yet had an acute event. Tailored programs maximize members' quality of life, and realize greater cost savings for members and clients.

Headquartered in Pennsylvania, KePRO also has offices in Florida, Maryland, Ohio, Tennessee, and Virginia. KePRO is URAC health utilization management and case management accredited. For more information, visit www.kepro.org.

For more information contact:
Joanne Benteler
Public Relations Director
717.265.7004

# # #

Read the full story at http://www.prweb.com/releases/KePRO/Shawn_Hanley/prweb2014954.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. ev3 Inc. Appoints Shawn McCormick as New Sr. Vice President and Chief Financial Officer
2. WuXi PharmaTech (NYSE: WX) Mourns the Tragic Loss of Its Independent Director Shawn Wang
3. LCA-Visions National Lasik Network Named as U.S. Provider for National Vision Administrators
4. QHR Employee, Cibola General CEO Named to AHA's Small or Rural Hospital Governing Council
5. Recent U.S. Ambassador to Tanzania Mark Green Named Managing Director of Malaria No More Policy Center
6. Medical City Hospital Named by Texas Monthly as One of the Top Ten Best Companies to Work for in Texas
7. Julie L. Novak Named Executive Director of Michigan State Medical Society
8. Dr. Patrick Cobb Named President of Community Oncology Alliance
9. Dave Annable Named Christopher & Dana Reeve Foundation Ambassador
10. FaxBack's Net SatisFAXtion Named a 2008 "Product of the Year" by TMC's Internet Telephony Magazine
11. St. Louis Named Top Asthma Capital for 2009
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Shawn Hanley Named KePRO Director of Business Development - Public Programs
(Date:3/24/2017)... ... 2017 , ... The law firm of Enea, Scanlan & Sirignano, LLP, ... resident Lauren C. Enea has joined the firm as an associate attorney. Ms. Enea, ... in elder law, Medicaid planning and applications, and Wills, Trusts and Estates. Samantha ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower ... upgrading their training and leads programs. , In February, 2017, Empower Brokerage introduced ... agents, Performance Partners is designed to teach how to maximize their sales efforts, ...
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: a dauntless and enlightened ... “End Time GPS” is the creation of published author, Wesley Gerboth, a World War ... munitions and space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God bestowed ...
(Date:3/24/2017)... ... ... “The Adventures of Joey, The Dog Who Barks at Puddles”: a boisterous story ... fullest, as God intended. “The Adventures of Joey, The Dog Who Barks at Puddles” ... passion for writing, especially about truth and human behavior. , Published by Christian Faith ...
(Date:3/23/2017)... ... ... The physicians of KSF Orthopaedic Center PA are proud to announce the ... located at 2255 E. Mossy Oaks Rd., Suite 440, Spring, Texas 77389 inside the ... living in the north Houston area (The Woodlands, Conroe, Magnolia, Kingwood, Humble) with an ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  A new genetic test has ... of individuals who carry HLA-B*15:02 and ... yet potentially deadly side effect of certain medications ... gene HLA-B*15:02 is strongly associated with ... syndrome and toxic epidermal necrolysis in patients treated ...
(Date:3/23/2017)... Prima BioMed has presented encouraging early signs ... combination with Keytruda, with one of the six melanoma ... response. Recruitment in the second cohort is complete and ... by Q317. Preliminary efficacy data from the 15-patient, run-in ... mid-year (recruitment in the 226-patient Phase IIb component is ...
(Date:3/23/2017)... New York , March 23, 2017 /PRNewswire/ ... market exhibits a consolidated vendor landscape with the top ... overall market in 2015. These companies are Stryker ... Inc., Hygia Health Services, Inc., and VANGUARD AG. ... reprocessed medical devices market is witnessing the prevalence ...
Breaking Medicine Technology: